Segmentation by Products & Services (Consumables, Instruments, Software, and Services); by Technology (Cell-Based Assays, Lab-on-a-Chip Technology, and Label-Free Technology); by Application (Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment, and Others); and by End-User – Global Demand Analysis & Opportunity Outlook 2020-2030
Buy NowGlobal High-Throughput Screening (HTS) Market TOC
Growth Drivers
Challenges
Regionally, the global high-throughput screening (HTS) market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in North America is expected to hold the highest market share by attaining the largest market revenue of USD 15722.9 Million by the end of 2030, up from a revenue of USD 7023.0 Million in the year 2020. The growth of the market in the region can primarily be attributed to the presence of a strong healthcare infrastructure, and for the presence of numerous healthcare companies who are working day in and out to develop advanced drugs and therapies to treat different diseases. According to the statistics by the World Bank, the current health expenditure, as a share of GDP, in North America, grew from 15.629% in the year 2013 to 16.415% in the year 2018. The market in the region is segmented by country into the United States and Canada, out of which, the market in the U.S. is expected to garner the highest market share throughout the forecast period and further grow with the highest CAGR of 8.6% during the forecast period.
On the other hand, the market in the Asia Pacific is expected to grow with the highest CAGR of 8.6% throughout the forecast period, on account of the rising demand for advanced medications, backed by the increasing prevalence of chronic diseases in the region. The Asia Pacific high-throughput screening market is segmented by country into China, India, Japan, South Korea, Vietnam, Singapore, Australia, and the Rest of Asia Pacific. Out of the market in these countries, the market in China is expected to garner the largest revenue of USD 2373.4 Million by the end of 2030, while the market in India is projected to grow with the highest CAGR of 9% during the forecast period.
The study further incorporates Y-O-Y Growth, market opportunities, demand & supply and forecast future opportunity in North America (United States, Canada, Mexico), South America, Europe (U.K., Germany, France, Italy, Spain, Hungary, BENELUX [Belgium, Netherlands, Luxembourg], NORDIC [Norway, Denmark, Sweden, Finland], Poland, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Malaysia, Indonesia, Taiwan, Hong Kong, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa).
The global high-throughput screening (HTS) market is segmented by products & services into consumables, instruments, software, and services. Out of these segments, the consumables segment is projected to hold the largest share of the market and further grow with the highest CAGR of 8.6% during the forecast period. The segment registered a revenue of USD 6937.73 Million in the year 2020 and is further expected to touch USD 15676.79 Million by the end of 2030. Further, on the basis of technology, the market is segmented into cell-based assays, lab-on-a-chip technology, and label-free technology, out of which, the cell-based assays segment garnered the largest revenue of USD 9468.04 Million in the year 2020, and is expected to touch USD 20832.83 Million by the end of 2030. By application, the market is segmented into target identification & validation, primary & secondary screening, toxicology assessment, and others, out of which, the target identification & validation segment is projected to garner the largest revenue of USD 16925.42 Million by the end of 2030. The global high-throughput screening market is also segmented on the basis of end-user into pharmaceutical & biotechnology companies, academic & government institutes, contract research organizations, and others. Amongst these segments, the pharmaceutical & biotechnology companies segment is expected to garner the largest revenue by the end of 2030 and also grow with the second-highest CAGR of 8.3% during the forecast period
Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global high-throughput screening (HTS) market that are included in our report are Agilent Technologies, Inc., Thermo Fisher Scientific, Tecan Trading AG, Promega Corporation, Hamilton Company, BPS Bioscience, Inc., PerkinElmer Inc., Merck KGaA, Carna Biosciences, Inc., Danaher Corporation, and others.
Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global high-throughput screening (HTS) market that are included in our report are Agilent Technologies, Inc., Thermo Fisher Scientific, Tecan Trading AG, Promega Corporation, Hamilton Company, BPS Bioscience, Inc., PerkinElmer Inc., Merck KGaA, Carna Biosciences, Inc., Danaher Corporation, and others.
June 17, 2021: Danaher Corporation announced that it would acquire the high-quality plasmid DNA, mRNA, and proteins manufacturer, Aldevron, for a cash price of around USD 9.6 Billion. The acquisition would help Danaher to expand their business portfolio in the field of genomic medicine.
In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.
Ans: The increasing adoption of open innovative models by biotech & pharmaceutical companies is one of the major factors anticipated to drive the market growth.
Ans: The market is anticipated to attain a CAGR of 8.4% over the forecast period, i.e., 2021-2030.
Ans: The complexities in the development of assays is one of the major factors estimated to hamper the market growth.
Ans: The market in the Asia Pacific to display significant business opportunities in the near future.
Ans: The major players in the market are Agilent Technologies, Inc., Thermo Fisher Scientific, Tecan Trading AG, Promega Corporation, Hamilton Company, BPS Bioscience, Inc., PerkinElmer Inc., Merck KGaA,, and others.
Ans: The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.
Ans: The market is segmented by products & services, technology, application, end-user, and by region.
Ans: The consumables segment is anticipated to grow with the highest CAGR of 8.6% during the forecast period and display significant growth opportunities.
Submit Your Request For Proposal (RFP)
